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ABSTRACT
International Journal of Exercise Science 8(4): 394-402, 2015. Endurance performance
and peak oxygen uptake (VO2peak) decline as altitude increases. Some data exist suggesting that
quercetin supplementation improves aerobic capacity in trained and untrained individuals at
sea-level (normobaric normoxic conditions). Few studies have examined the effects of quercetin
on endurance performance during simulated altitude exposure (normobaric hypoxic conditions).
The purpose of this study was to determine the effects of consuming 1000 mg·day -1 of quercetin
for two weeks on cycling VO2peak in healthy trained male cyclists performing under normobaric
normoxic and hypoxic conditions (NP and HP, respectively). Fourteen age-matched healthy male
subjects were randomized to either a placebo or quercetin group. Baseline and post
supplementation VO2peak values were quantified during incremental cycling under normobaric
normoxic (FIO2 = 20.9%) and normobaric hypoxic (FIO2 = 13.6 + 0.2%) conditions. Subjects
consumed capsules twice daily with either 500 mg quercetin or placebo (Tang) for two weeks and
were re-assessed. Test order was randomized and assessments were separated by 48-72 hours. At
baseline, there were no significant differences between groups for VO 2peak normobaric normoxic
trials (NPbaseline Placebo vs. NPbaseline Quercetin = 58.7+8.8 and 61.5+7.9 ml . kg-1 . min-1,
respectively, p = 0.541) and normobaric hypoxic trials (HPbaseline Placebo vs. HPbaseline Quercetin =
48.5+8.3 and 50.8+4.8 ml . kg-1 . min-1, respectively, p = 0.534). No significant differences were
found after treatment (Placebo: NPbaseline vs. NPpost = 58.7+ 8.8 and 56.7+7.4 ml . kg-1 . min-1,
respectively, p = 0.10; HPbaseline vs .HPpost = 48.5+8.3 and 47.1+8.3, respectively, p = 0.50;
Quercetin: NPbaseline vs. NPpost = 61.5+7.9 and 62.4+7.3 ml . kg-1 . min-1, respectively, p = 0.558;
HPbaseline vs. HPpost = 50.8+4.8 and 51.2+3.8 ml . kg-1 . min-1, respectively, p= 0.656. These data
suggest that short-term quercetin supplementation at 1000 mg . day-1 does not affect VO2peak
elicited via incremental maximal cycle testing under normobaric normoxic and hypoxic
conditions in trained male cyclists. Furthermore, quercetin supplementation did not attenuate the
decline in VO2peak that was evident in the normobaric hypoxic condition.
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INTRODUCTION
In recent years, much attention has been
given to the role of dietary antioxidants in

preventing disease and improving overall
health.
Quercetin, a polyphenolic
flavonoid, is a naturally occurring
substance that is found in a variety of food.

QUERCETIN SUPPLEMENTATION AND SIMULATED ALTITUDE PERFORMANCE
Common food sources of quercetin include
tea, onions, apples, peppers, blueberries
and dark green vegetables, with the
average intake of U.S. adults at
approximately 4 mg . day-1. However, daily
intakes may be as high as 200 – 500 mg in
individuals consuming a diet high in fruits
and vegetables (5). Although not entirely
conclusive, epidemiologic studies provide
evidence that self-selected diets high in
quercetin may play a role in preventing
various diseases. High quercetin intake has
been linked to a reduced risk of colorectal,
kidney, pancreatic, prostate, and lung
cancer, as well as cardiovascular disease
(10, 11, 29). In vitro, animal, and human
studies have shown that quercetin
possesses antioxidant, anti-carcinogenic,
anti-inflammatory, and cardioprotective
properties (3, 12, 14, 23, 26). In addition,
there is evidence that quercetin may lower
blood pressure through vasodilatory effects
(14, 19). Based on these studies, quercetin
appears to have significant health benefits.

exercise tolerance (20, 21). Furthermore,
recent evidence from both animal and
human studies suggests that quercetin
supplementation resulted in increased
mitochondrial capacity, oxidative enzyme
activity, and increased time to exhaustion
(8, 9). Additional data show that quercetin
may cause vasodilation, resulting in
improved blood flow (5, 18, 22).
An
increase in blood flow to working muscle,
coupled with an increase in mitochondrial
density, could result in improved
endurance performance by increasing an
individual’s aerobic capacity and fat
utilization. Although these data support
the use of quercetin to improve aerobic
performance, other studies have shown that
quercetin has no effect on aerobic capacity
(1, 6). More work is needed in this area to
better define the efficacy of quercetin in
improving athletic performance under
various conditions.
It is well established that altitude decreases
VO2peak in humans and evidence suggests
that oxidative stress increases at altitude
(16, 27). Consequently, the use of
nutritional
interventions,
such
as
antioxidant supplementation to enhance
antioxidant capacity and prevent and/or
treat symptoms of acute mountain sickness
has gained attention. Although justification
for their use is not based on scientific
evidence, Ginkgo Biloba and Hippophae
rhamnoides L. have been used for centuries
in Chinese and Tibetan medicine to combat
AMS (24). Data from Purushothama et al.
(2008) show that H. rhamnoides exerted a
protective effect in rats exposed to hypoxia
(24). Quercetin is a major component of
this supplement (30). However, there is
very limited data regarding the efficacy of
isolated quercetin in attenuating the effects

Because of the purported health benefits of
quercetin, investigators have begun to
examine the efficacy of quercetin in
improving athletic performance. Regular
aerobic exercise can increase muscle
mitochondrial density by 20% to 100%,
depending on the workload (13). This
increase
in
mitochondrial
density
contributes to improved fitness and
performance by increasing the aerobic
capacity of skeletal muscle. Limited data
show that quercetin may have the ability to
induce mitochondrial biogenesis and
improve aerobic exercise performance.
Human studies have shown that daily
supplementation of quercetin (500 mg twice
daily) improves aerobic capacity, time to
exhaustion, time trial performance, and
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of hypoxia in vivo. Zhou et al. investigated
the protective effect of quercetin in rats
exposed to a chronic (23 h per day)
hypobaric, hypoxic environment (31).
Quercetin attenuated the decline in blood
pH, PO2, SpO2, and PCO2 that occurred in
the control group. In addition, quercetin
increased nitric oxide levels, a potent
vasodilator (31). Based on this limited data,
it is plausible that quercetin may exert
protective effects in an individual exposed
to a hypoxic environment.

enhancing aerobic performance and fat
utilization at altitude. The overall goal of
this investigation is to examine the effect of
quercetin on peak oxygen uptake (VO2peak)
in trained individuals exercising under
normobaric
normoxic
and
hypoxic
conditions.
METHODS
Participants
Fourteen healthy male subjects (age: 38.9 +
9.8 y, weight: 75.7 + 7.9 kg) were recruited
through flyers posted on the Castleton State
College campus and throughout the
Rutland
community,
and
through
solicitation of the Killington Pico Cycling
Club. Prior to data collection, participants
were advised of the possible risks, methods,
and potential benefits of participation in the
study. A health history questionnaire and
informed consent (approved by the
Castleton State College Institutional Review
Board for research involving human
subjects) was completed by each subject.

Significant reductions in VO2peak generally
occur at an altitude of 1,500 to 1,600 m
(5,000 ft). Beyond this altitude, VO2peak
decreases approximately 8% to 11% for
every 1,000 m increase (or 3% for every
1,000 ft increase) (27). In addition, variables
such as heart rate, ventilation, and
perception of fatigue, at rest and during
exercise, are increased at higher elevation.
The lack of oxygen at altitude also affects
substrate metabolism. At altitude, there is
an increased reliance carbohydrate for fuel
since this substrate can be metabolized
anaerobically (4, 17). Therefore, aerobic
exercise at altitude may be limited, in part,
by glycogen depletion, as this is a very
limited fuel supply. Due to the detrimental
effect of altitude on athletic performance,
many studies have investigated various
nutritional strategies in an effort to offset
the performance decrement typically seen
in an individual performing in that
environment.
Recent studies have
examined the efficacy of antioxidants and
other nutritional supplements in 1)
attenuating the decline in VO2max and 2)
enhancing fat utilization, thus sparing
glycogen, in individuals exercising at
altitude. However, there is very limited
data regarding the efficacy of quercetin in
International Journal of Exercise Science

Protocol
Subjects
were
age-matched
and
randomized to either a placebo group
(consumed one capsule twice daily with
500 mg Tang from the Kraft Foods
Company, Northfield, IL) or quercetin
supplementation group (consumed one
capsule with 500 mg twice daily with
quercetin from Jarrow Formulas, Los
Angeles, CA) in a double-blind design.
Subjects had no significant recent exposure
to altitude training or racing and were
asked to maintain their typical training and
dietary routines for the duration of the
study. Subjects were instructed to refrain
from strenuous exercise and excessive
alcohol for 24 hours prior to testing.
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Subjects maintained a dietary record for 48
hours prior to initial testing and were asked
to match it as closely as possible for each
successive trial. All maximal trials were
separated by 48-72 hours.
Metabolic data was collected using a
ParvoMedics
metabolic
system
(ParvoMedics, Salt Lake City, UT). All
testing
was
conducted
using
an
electronically-braked
cycle
ergometer
designed to interface with the subject’s
personal cycle of choice (Velotron DynaFit
Pro, Seattle, WA). Subjects completed a five
minute warm-up at a workload of 50 watts
at the start of each trial. Using a continuous
incremental protocol, workload increased
by 25 watts per minute until volitional
exhaustion was achieved. All tests were
terminated after subjects failed to maintain
their final workload for 15 seconds and/or
voluntarily identified that their maximal
effort was achieved. VO2peak was identified
as the highest value recorded during the
final workload achieved by each subject.
Subjects performed cycling trials under
normobaric normoxic conditions (FIO2 =
20.9%, 752 + 4 mmHg) and hypoxic
conditions (FIO2 = 13.6 + 0.2%, 754 + 3
mmHg; simulated approximately 3600
meters above sea-level). Baseline and post
treatment normoxic and hypoxic trials were
randomized and subjects were not
informed of the trial condition. Hypoxic
conditions were produced using a hypoxic
generator (Colorado Altitude Training,
Louisville, CO) connected to two, 200 L
Douglas bags that were used to create a
reservoir of inspiratory gas for the subjects
during hypoxic trials (Figure 1). In order to
avoid subject bias, this method was also
used during the normoxic trials with the
Douglas bags filled with 20.9% O2.
International Journal of Exercise Science

Figure 1. Experimental set up.

Statistical Analysis
A MANOVA examined oxygen level
(normoxia/hypoxia),
quercetin
supplementation, and time as independent
variables and VO2peak and power (w) as
dependent variables (Wilks’ λ = .095, F(9,4)
= 4.24, p = .09). Univariate ANOVAs
examined
differences
in
individual
dependent variables. Thereafter, post-hoc ttests were used to examine pair-wise
differences. Using Bonferroni correction, a
family-wise alpha of .05 was maintained for
all post-hoc pair-wise comparisons.
RESULTS
VO2peak was not different between groups at
baseline for normobaric normoxic trials
(placebo vs. quercetin group = 58.7+8.8 and
61.5+7.9 ml . kg-1. min-1, respectively, t(12) =
-.63, p = 0.54) (Table 1) and hypoxic trials
(placebo vs. quercetin group = 48.5+8.3 and
50.8 + 4.8 ml . kg-1. min-1, respectively, t(12)
= -.64, p = 0.53) (Table 2). There was no
statistically significant difference found in
VO2peak during normoxic trials for the
placebo group when comparing baseline
values to post placebo supplementation
values (58.7 + 8.8 and 56.7 + 7.4 ml . kg-1.
min-1, respectively, t(6) = 1.95, p = 0.10
(Table 1).
There was no statistically
397
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Table 2. Mean (+ SD) results for VO2peak during
hypoxic trials for placebo and quercetin
supplementation groups.

significant difference found in VO2peak
during hypoxic trials for the placebo group
when comparing baseline values to post
placebo supplementation values (48.5 + 8.3
and 47.1 + 8.3 ml . kg-1. min-11, respectively,
t(6) = .72, p = 0.50 (Table 2). There was no
statistically significant difference found in
VO2peak during normoxic trials for the
quercetin supplementation group when
comparing baseline values to post
supplementation values (61.5 + 7.9 and 62.4
+ 7.3 ml . kg-1. min-1, respectively, t(6) = -.62,
p = 0.56) (Table 1). There was no statistically
significant difference found in VO2peak
during hypoxic trials for the quercetin
supplementation group when comparing
baseline values to post supplementation
values (50.8 + 4.8 and 51.2 + 3.8 ml . kg-1.
min-1, respectively, t(6) = -.47, p = 0.66)
(Table 2). As expected, VO2peak for all
hypoxic trials was significantly (p < 0.05)
reduced when compared with normoxic
trials (baseline normoxia vs. baseline
hypoxia and post normoxia vs. post
hypoxia) trails for all groups (range = 16.9% to -17.9% of baseline VO2peak) (Table
3). These data suggest that short-term
quercetin supplementation for 2 weeks at
1000 mg . day-1 does not improve VO2peak in
healthy trained male cyclists performing
under normobaric normooxic and hypoxic
laboratory conditions.

Hypoxic Trials
Placebo baseline
Placebo post
Quercetin baseline
Quercetin post

Table 3. Mean (+ SD) results for VO2peak comparing
normoxic and hypoxic trials for placebo and
quercetin supplementation groups.
Normoxic vs. Hypoxic Trials Peak VO2
(ml . kg-1 . min-1)
Normoxic Hypoxic
Placebo baseline
58.7 + 8.8
Placebo post
56.7 + 7.4
Quercetin baseline 61.5 + 7.9
Quercetin post
62.4 + 7.3
†p < 0.0125 (pair-wise)

Placebo baseline
Placebo post
Quercetin baseline
Quercetin post

The primary purpose of this investigation
was to evaluate the effects of quercetin
supplementation
on
VO2peak
during
incremental
cycle
ergometry
under
normobaric hypoxic conditions that
simulated approximately 3600 meters of
elevation above sea-level. In addition, the
effect of quercetin supplementation on
VO2peak during normobaric normoxic/sealevel conditions was investigated. We
report no beneficial effects of 1000 mg . day1 of quercetin supplementation for two
weeks on VO2peak under both hypoxic and
normoxic conditions. While VO2peak
responses to normobaric hypoxia after
quercetin supplementation have not been
studied, our findings are consistent with
others who have reported no beneficial
effects to endurance performance and
aerobic capacity after short-term (i.e., 2 - 4

Peak VO2
(ml . kg-1 . min-1)
58.7 + 8.8*
56.7 + 7.4*
61.5 + 7.9*
62.4 + 7.3*

International Journal of Exercise Science

48.5 + 8.3
47.1 + 8.3
50.8 + 4.8
51.2 + 3.8

%
Decline
17.4†
16.9†
17.4†
17.9†

DISCUSSION

Table 1. Mean (+ SD) results for VO2peak during
normoxic trials for placebo and quercetin
supplementation groups.
Normoxic Trials

Peak VO2
(ml . kg-1 . min-1)
48.5 + 8.3**
47.1 + 8.3**
50.8 + 4.8 **
51.2 + 3.8 **
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weeks) quercetin supplementation (3, 4).
Our findings are contrary to those who
reported that quercetin supplementation
improved cycling efficiency, aerobic
capacity, fat utilization, and time trial
performance in both trained and untrained
individuals (7, 8, 9, 21).

long term benefits associated with the
supplement. These researchers reported a
28% reduction in VO2peak at 4300 meters in
both the control and treatment groups.
Similarly, we found that VO2peak decreased
by approximately 17% in both the placebo
and quercetin supplementation group
under normobaric hypoxic condition
studied
here
(approximately
3600m
simulated altitude), however there were no
significant differences in VO2peak associated
with quercetin supplementation.

Due to controversial findings related to the
effects of quercetin supplementation on
factors related to endurance performance in
humans and animals, researchers have
addressed the methodological variability of
several of these studies. Jin and colleagues
(2010) have questioned the bioavailability
of extracted/processed verses natural
forms of quercetin, suggesting that natural
forms may be superior to processed forms.
We chose a processed form for this
investigation as dosage was easily
controlled. Dosage has also varied from
study to study. The 1000 mg . day-1 used
here is among the higher doses studied,
although even higher doses may be needed
to yield beneficial effects (15). It is possible
that longer duration supplementation (i.e.,
> 4 weeks) and/or higher doses may be
necessary to induce structural and
functional biological changes that could
enhance endurance performance or VO2peak
under hypoxic conditions.

Given that some studies have documented
increased mitochondrial RNA, increased
muscle blood flow and decreased blood
pressure in response to quercetin
supplementation, we felt that quercetin
supplementation could be particularly
beneficial to endurance athletes exercising
at altitude. Our findings indicate no
beneficial effects of short-term quercetin
supplementation
on
VO2peak during
maximal cycle ergometry testing at a
simulated altitude of approximately 3600
meters. The dose used in this investigation
was determined based on evidence from
previous research reporting enhanced
endurance performance after 1-4 weeks of
quercetin supplementation at similar doses
to those used here (20, 21). Human studies
have shown that daily supplementation of
quercetin (500 mg twice daily) improves
aerobic capacity (VO2max), time to
exhaustion, time trial performance, and
exercise tolerance (20, 21). Furthermore,
recent evidence from both animal and
human studies suggests that quercetin
supplementation resulted in increased
mitochondrial capacity, oxidative enzyme
activity, and increased time to exhaustion
(8, 9). Additional data show that quercetin
may cause vasodilation, resulting in

To our knowledge, the influence of
quercetin supplementation on VO2peak
during simulated altitude using normobaric
hypoxia has not been investigated. Subudhi
et al. (25) studied the effects of a
combination of antioxidants on ventilatory
threshold at altitude and reported that 30
days of supplementation improved acute
ventilatory
kinetics
associated
with
adaptive responses to hypobaric hypoxia
(4300meters), but there appeared to be no
International Journal of Exercise Science
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improved blood flow (18, 21, 22). An
increase in blood flow to working muscle,
coupled with an increase in mitochondrial
density, could result in improved
endurance performance by increasing an
individual’s aerobic capacity and fat
utilization. Although these data support
the use of quercetin to improve aerobic
performance, our findings support those of
others who have shown that quercetin has
no effect on aerobic capacity as indicated by
VO2peak (1,6).

necessarily represent the official views of
NIGMS or NIH.

In conclusion, potential beneficial effects of
quercetin supplementation that may be
particularly
relevant
to
endurance
performance at altitude may involve
structural changes at the muscle cell and
vascular level (i.e., increased mitochondrial
density, improved vasodilatory responses),
therefore,
longer
durations
of
supplementation should be studied.
Further, bioavailability of various forms of
quercetin should be considered and natural
forms of quercetin supplementation should
be evaluated. Another area for study is the
effects of quercetin supplementation and
dose-response kinetics on untrained
individual performing at altitude as these
individuals may benefit more significantly
from potential upregulation of structural
components supporting VO2peak and
endurance performance at altitude.

3. Boomgaarden I, Egert S, Rimbach G, Wolffram S,
Muller MJ, Doring F. Quercetin supplementation
and its effect on human monocyte gene expression
profiles in vivo. Br J Nutr 104(3): 336-345, 2010.
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